EUVIMEDEUVIMED entdecken
Crossref

p-Tau/Aβ42 ratio associates with cognitive decline in Alzheimer’s disease, mild cognitive impairment, and cognitively unimpaired older adults.

Michael R McKenna iD, Oyetunde Gbadeyan, Rebecca Andridge, Matthew W Schroeder, Erika A Pugh, Douglas W Scharre, Ruchika S Prakash iD

Neuropsychology · 2025-02 · 39 (2) · 137-151

DOI: 10.1037/neu0000987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychology, 2025-02. Verfasst von Michael R McKenna und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University, Department of Psychology. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Amyloid beta-Peptides, Alzheimer Disease, tau Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Gefördert von: NIH HHS, Department of Defense ADNI, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionAmyloid beta-PeptidesAlzheimer Diseasetau ProteinsPeptide FragmentsHumansAgedMaleFemaleExecutive FunctionAged, 80 and overMemory, EpisodicNeuropsychological TestsBiomarkers

Substanzen

Amyloid beta-Peptidestau ProteinsPeptide Fragmentsamyloid beta-protein (1-42)BiomarkersMAPT protein, human

Autor:innen und Institutionen

  • The Ohio State University, Department of Psychology.
  • Monash University, Faculty of Medicine, National Centre of Healthy Ageing, Peninsula Clinical School.
  • The Ohio State University, Division of Biostatistics.
  • The Ohio State University Wexner Medical Center, Department of Neurology, Cognitive Neurology Division.

ORCID-Profile: Michael R McKenna, Ruchika S Prakash

Förderung

  • NIH HHS
  • Department of Defense ADNI
  • National Institutes of Health

Zitieren

APA

McKenna, M. R., Gbadeyan, O., Andridge, R., Schroeder, M. W., Pugh, E. A., Scharre, D. W., & Prakash, R. S. (2025). p-Tau/Aβ42 ratio associates with cognitive decline in Alzheimer’s disease, mild cognitive impairment, and cognitively unimpaired older adults. Neuropsychology, 39(2), 137-151. https://doi.org/10.1037/neu0000987

Vancouver

McKenna MR, Gbadeyan O, Andridge R, Schroeder MW, Pugh EA, Scharre DW, et al. p-Tau/Aβ42 ratio associates with cognitive decline in Alzheimer’s disease, mild cognitive impairment, and cognitively unimpaired older adults. Neuropsychology. 2025;39(2):137-151. doi:10.1037/neu0000987

BibTeX
@article{McKenna2025,
  author = {McKenna, Michael R and Gbadeyan, Oyetunde and Andridge, Rebecca and Schroeder, Matthew W and Pugh, Erika A and Scharre, Douglas W and Prakash, Ruchika S},
  title = {p-Tau/Aβ42 ratio associates with cognitive decline in Alzheimer’s disease, mild cognitive impairment, and cognitively unimpaired older adults},
  journal = {Neuropsychology},
  year = {2025},
  volume = {39},
  number = {2},
  pages = {137--151},
  doi = {10.1037/neu0000987}
}
Kostenlos starten →